10 YEARS EXPERIENCE OF TYROSINE KINASE INHIBITOR THERAPY FOR CML IN A SINGLE UK CENTRE: COMPARISON WITH PRE-TKI ERA AND EVALUATION OF 2013 ELN GUIDELINESD Khan,N Roy, V Bari, G Vallance, H Dreau,T Littlewood,Andrew Peniket,Paresh Vyas,L Foroni,Anna Schuh,Adam MeadHAEMATOLOGICA（2014）引用 23|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
